AYTU · NASDAQ · Drug Manufacturers - Specialty & Generic

Aytu BioPharma

Commercializer of prescription medicines for depression, ADHD, and pediatric conditions.

$2.25
After-hours close0.00 (0.00%)
At close$2.25(+0.45%)
DateEstimateReportedSurprise
Sep 2026−$0.29
Sep 2026−$0.22
May 2026−$0.31−$0.53−71.0%
Feb 2026−$0.26−$1.05−303.8%
Nov 2025−$0.06−$0.08−33.3%
Sep 2025−$0.02−$0.26−1,200.0%

The latest year is open to everyone — the 40 quarters behind it read with an account.

Sign in
May 2025
Feb 2025
Nov 2024
Sep 2024
May 2024
Feb 2024
Nov 2023
Sep 2023
May 2023
Feb 2023
Nov 2022
Sep 2022
May 2022
Feb 2022
Nov 2021
Sep 2021
May 2021
Feb 2021
Nov 2020
Oct 2020
May 2020
Feb 2020
Nov 2019
Sep 2019
May 2019
Feb 2019
Nov 2018
Sep 2018
May 2018
Feb 2018
Nov 2017
Aug 2017
May 2017
Feb 2017
Nov 2016
Sep 2016
May 2016
May 2016
Nov 2015
Sep 2015
Report dateEPS estEPSSurpriseRevenue estRevenueSurprise
Sep 29, 2026−$0.29$12.3M
Sep 22, 2026−$0.22$17.2M
May 13, 2026−$0.31−$0.53−71.0%$12.1M$12.4M+3.0%
Feb 3, 2026−$0.26−$1.05−303.8%$12.2M$15.2M+24.9%
Nov 13, 2025−$0.06−$0.08−33.3%$12.6M$13.9M+10.2%
Sep 23, 2025−$0.02−$0.26−1,200.0%$17.9M$15.1M−15.5%

The latest year is open to everyone — the 40 quarters behind it read with an account.

Sign in
May 14, 2025
Feb 12, 2025
Nov 13, 2024
Sep 26, 2024
May 15, 2024
Feb 14, 2024
Nov 14, 2023
Sep 27, 2023
May 11, 2023
Feb 21, 2023
Nov 14, 2022
Sep 27, 2022
May 16, 2022
Feb 14, 2022
Nov 15, 2021
Sep 27, 2021
May 17, 2021
Feb 11, 2021
Nov 12, 2020
Oct 6, 2020
May 14, 2020
Feb 13, 2020
Nov 14, 2019
Sep 26, 2019
May 14, 2019
Feb 7, 2019
Nov 7, 2018
Sep 6, 2018
May 14, 2018
Feb 8, 2018
Nov 9, 2017
Aug 31, 2017
May 11, 2017
Feb 9, 2017
Nov 7, 2016
Sep 1, 2016
May 11, 2016
May 4, 2016
Nov 6, 2015
Sep 30, 2015